癌症干细胞标志物与缺氧诱导基因表达在接受术后放疗的局部晚期头颈鳞癌患者中的预后价值独立验证
该研究回顾性分析152例接受术后放疗的局部晚期HNSCC患者,验证HPV状态、CSC标志物表达和肿瘤缺氧状态对预后的影响。单因素分析验证了HPV感染状态、SLC3A2表达和缺氧状态组合的预后价值,多因素模型C指数为0.58–0.69。结论认为这些标志物是潜在的预后生物标志物。
要点
- 在独立验证队列中验证了HPV状态、CSC标志物SLC3A2表达和缺氧状态组合的预后价值。
- 多因素模型C指数为0.58–0.69,显示良好的预后性能。
- 纳入CD44和15基因缺氧特征较无CSC标志物或缺氧分类器的基线模型有适度改善。
核心结论
- HPV状态、CD44和SLC3A2的CSC标志物表达以及缺氧状态是接受术后放疗的局部晚期HNSCC患者的潜在预后生物标志物。
研究设计与样本
- 回顾性分析152例局部晚期HNSCC患者,其中40例接受术后放化疗,验证HPV16 DNA状态、CSC标志物表达和缺氧相关基因特征对术后放疗结局的影响。
- 使用一致性指数作为性能指标验证先前研究中的Cox模型,主要终点为局部区域控制。
主要发现
- 局部区域控制、无远处转移生存和总生存均低于先前报道的队列。
- 单因素分析验证了HPV感染状态、CSC标志物SLC3A2表达和肿瘤缺氧状态组合的预后价值。
- 多因素模型的一致性指数在验证中为0.58–0.69,表明模型具有良好的预后性能。
- 纳入CD44和15基因缺氧特征较无CSC标志物或缺氧分类器的基线模型有适度改善。
临床怎么用
- HPV状态、CD44和SLC3A2表达及缺氧状态可作为局部晚期HNSCC术后放疗患者的预后评估参考。
局限性
- 研究为回顾性分析,部分患者接受术后放化疗,结果需进一步前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To validate the impact of HPV status, cancer stem cell (CSC) marker expression and tumour hypoxia status in patients with locally advanced head and neck squamous cell carcinoma (HNSCC), who received postoperative radiotherapy. The results of the exploration cohort have previously been reported by the German Cancer Consortium Radiation Oncology Group (DKTK-ROG; Lohaus et al., 2014; Linge et al., 2016). MATERIALS AND METHODS: For 152 patients with locally advanced HNSCC the impact of HPV16 DNA status, CSC marker expression and hypoxia-associated gene signatures on outcome of postoperative radiotherapy were retrospectively analysed. Out of them, 40 patients received postoperative radiochemotherapy. Cox models presented in a previous study were validated using the concordance index as a performance measure. The primary endpoint of this study was loco-regional control. Results were compared to those previously reported by DKTK-ROG. RESULTS: Loco-regional control, freedom from distant metastases and overall survival were inferior to the previously reported cohort. Despite of this, the prognostic value of the combination of HPV infection status, CSC marker expression (SLC3A2) and tumour hypoxia status could be validated in univariate analyses using an independent validation cohort. For multivariate models, the concordance index was between 0.58 and 0.69 in validation, indicating a good prognostic performance of the models. The inclusion of CD44 and the 15-gene hypoxia signature moderately improved the performance compared to a baseline model without CSC markers or hypoxia classifiers. CONCLUSIONS: The HPV status, CSC marker expression of CD44 and SLC3A2 as well as hypoxia status are potential prognostic biomarkers for patients with locally advanced HNSCC treated by postoperative radiotherapy.
引用
- Linge A, Löck S, Krenn C, et al. Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy. Clin Transl Radiat Oncol. 2016. PMID: 29657990. doi:10.1016/j.ctro.2016.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。